SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : STEM -- StemCells, Inc.
STEM 18.75-0.4%Nov 11 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (263)6/25/1999 9:15:00 AM
From: LLCF  Read Replies (2) of 805
 
Time to repeat this:

Message 9686199

And this by Rick:

"I'm not much of an encapsulation fan."

Message 9703286

Nice call Rick.

Company says:

"The Company plans to continue to aggressively pursue research, development and commercialization of its broad, proprietary stem/progenitor cell technology platforms. CytoTherapeutics' patent estate covering its stem cell technology consists of 10 issued US patents and 28 US patent applications."

Well, they have about 1 years worth of cash left they BETTER be agressive! Into the clinic next week, P1 in Sept., P2 in Jan and a partner in the 1st quarter??? Yea, thats the ticket...

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext